Comparative assessment of off-label and unlicensed drug prescription in neonatal intensive care: FDA versus Brazilian guidelines

MLA

Haline Tereza Matias de Lima Costa, et al. “Comparative Assessment of Off-Label and Unlicensed Drug Prescription in Neonatal Intensive Care: FDA versus Brazilian Guidelines.” Anales de Pediatría (English Edition), vol. 94, no. 3, Mar. 2021, pp. 153–60. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....5e56fd1bcc60a4856626db59469e310a&authtype=sso&custid=ns315887.

APA

Haline Tereza Matias de Lima Costa, Tatiana Xavier Costa, Flavia Evelyn Medeiros Fernandes, Priscilla Karilline do Vale Bezerra, Arlan Peres Florencio, Martins Rand Randall, & Jéssica Escorel Chaves Cavalcanti. (2021). Comparative assessment of off-label and unlicensed drug prescription in neonatal intensive care: FDA versus Brazilian guidelines. Anales de Pediatría (English Edition), 94(3), 153–160.

Chicago

Haline Tereza Matias de Lima Costa, Tatiana Xavier Costa, Flavia Evelyn Medeiros Fernandes, Priscilla Karilline do Vale Bezerra, Arlan Peres Florencio, Martins Rand Randall, and Jéssica Escorel Chaves Cavalcanti. 2021. “Comparative Assessment of Off-Label and Unlicensed Drug Prescription in Neonatal Intensive Care: FDA versus Brazilian Guidelines.” Anales de Pediatría (English Edition) 94 (3): 153–60. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....5e56fd1bcc60a4856626db59469e310a&authtype=sso&custid=ns315887.